DFPG Investments’s Pfizer PFE Stock Holding History

DFPG Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$1.59M	Sell	53,539 -45,377	-46%	-$1.37M	0.12%	165
2023 Q3	$2.94M	Buy	98,916 +40,183	+68%	+$1.42M	0.27%	94
2023 Q2	$2.14M	Buy	58,733 +19,966	+52%	+$777K	0.19%	123
2023 Q1	$1.58M	Buy	38,767 +8,646	+29%	+$373K	0.17%	129
2022 Q4	$1.43M	Buy	30,121 +23,671	+367%	+$1.13M	0.24%	102
2022 Q3	$290K	Sell	6,450 -3,519	-35%	-$171K	0.12%	128
2022 Q2	$506K	Buy	9,969 +3,850	+63%	+$196K	0.22%	82
2022 Q1	$317K	Sell	6,119 -279	-4%	-$14.5K	0.12%	115
2021 Q4	$346K	Buy	6,398 +912	+17%	+$45.2K	0.14%	118
2021 Q3	$229K	Buy	+5,486	New	+$243K	0.09%	157
2019 Q3	–	Sell	-6,986	Closed	-$287K	–	175
2019 Q2	$287K	Sell	6,986 -2,439	-26%	-$96.8K	0.27%	110
2019 Q1	$382K	Sell	9,425 -293	-3%	-$11.7K	0.41%	79
2018 Q4	$402K	Buy	+9,718	New	+$403K	0.53%	69

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

DFPG Investments's PFE Position: Q4 2023 in Review

DFPG Investments reduced its Pfizer (PFE) stake by 46% in Q4 2023, selling an estimated $1.37M and leaving 53,539 shares worth $1.59M. The position accounts for 0.12% of the portfolio, ranked #165.

DFPG Investments first reported a position in PFE in Q4 2018 and has held it in 13 quarters since. The position peaked at $2.94M in Q3 2023. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

DFPG Investments held 53,539 shares of Pfizer worth $1.59M as of Q4 2023.
DFPG Investments sold 45,377 Pfizer shares in Q4 2023, an estimated $1.37M.
Pfizer made up 0.12% of DFPG Investments's portfolio in Q4 2023, its #165 holding.
DFPG Investments first reported a position in Pfizer in Q4 2018 and has held it in 13 quarters since.
DFPG Investments's Pfizer position peaked at $2.94M in Q3 2023.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on DFPG Investments's 13F filing for Q4 2023, filed 10 Jan 2024.